Development And Validation Of New Stability Indicating Method For Assay Of Pitavastatin In Solid Oral Dosage Form.
DOI:
https://doi.org/10.53555/sfs.v8i3.1911Keywords:
Pitavastatin, RP-HPLC, Analytical techniques, Validation, stability-indicating analysisAbstract
To explore recent advancements in HPLC instrumentation and column technology for stability-indicating analysis. Pitavastatin (PVS) is a synthetic competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and a very effective lipid-lowering medication. Aim of this study was to develop, optimize and validate novel stability-indicating RP-HPLC methods for Pitavastatin in solid oral dosage forms.